Table 2. FACS analysis of CD45RA subset... | American Society of Hematology

Table 2.

FACS analysis of CD45RA subset composition in thymomas of MG(+) and MG(−) patients, gated on CD3⁺ T cells

Patient	Case number	WHO thymoma subtype	MG	CD4-CD8 ratio	CD45RA⁺cells, % CD3	% CD45RA⁺ CD3⁺
Patient	Case number	WHO thymoma subtype	MG	CD4-CD8 ratio	CD45RA⁺cells, % CD3	CD4	CD8
1	94/24 864	AB	Yes	0.24	26.0	10.6	15.4
2	98/5 633	AB	Yes	1.8	32.6	10.0	22.6
3	99/13 575	B2	Yes	1.2	52.0	26.7	25.3
4	95/1 064	B2	Yes	1.2	52.1	24.4	27.7
5	00/25 907	B2	Yes	0.58	41.7	27.1	14.6
6	00/22 717	B2	Yes	0.57	48.8	12.1	36.8
7	00/20 223	B2 of B3	Yes	0.79	93.7	71.4	22.3
8	99/21 994	B2	Yes	3.0	74.5	22.7	51.7
9	99/3 983	B2	Yes	4.2	21.7	14.6	7.1
Average, patients 1-9				1.51	49.2 ± 23.1	24.4 ± 18.9	24.8 ± 13.2
10	95/15 091	AB	No	0.5	6.8	2.5	4.5
11	00/21 586	AB	No	0.3	46.9	5.6	41.4
12	95/12 211	AB	No	0.16	8.9	2.9	6.0
13	00/1 495	AB	No	0.11	12.7	2.7	10.0
14	01/4 054	AB	No	0.18	18.9	4.2	14.7
15	01/261	AB	No	0.26	24.0	3.7	20.7
16	93/23 169	B2	No	0.45	16.1	4.5	11.6
17	00/3 045	B2	No	1.8	17.6	9.8	7.8
18	97/6 635	B2	No	0.06	46.9	2.4	44.5
19	01/5 447	B2	No	0.26	27.0	5.2	22.1
20	98/5 186	B2 + B3	No	0.12	13.2	3.1	10.1
21	01/6 600	B2 + B3	No	0.25	14.1	4.3	9.9
22	97/20 308	B2 + B3	No	0.16	41.4	5.1	36.3
Average, patients 10-22				0.35	20.1 ± 15.2	4.3 ± 2.0	18.4 ± 13.7
23-35 thymus controls		TFH	Yes	1.0-3.3	17.6-55.6	8.1-32.8	9.5-22.2
Average, patients 23-35 thymus controls				2.5	33.7 ± 12.7	19.1 ± 10.6	12.9 ± 3.9

Patient	Case number	WHO thymoma subtype	MG	CD4-CD8 ratio	CD45RA⁺cells, % CD3	% CD45RA⁺ CD3⁺
Patient	Case number	WHO thymoma subtype	MG	CD4-CD8 ratio	CD45RA⁺cells, % CD3	CD4	CD8
1	94/24 864	AB	Yes	0.24	26.0	10.6	15.4
2	98/5 633	AB	Yes	1.8	32.6	10.0	22.6
3	99/13 575	B2	Yes	1.2	52.0	26.7	25.3
4	95/1 064	B2	Yes	1.2	52.1	24.4	27.7
5	00/25 907	B2	Yes	0.58	41.7	27.1	14.6
6	00/22 717	B2	Yes	0.57	48.8	12.1	36.8
7	00/20 223	B2 of B3	Yes	0.79	93.7	71.4	22.3
8	99/21 994	B2	Yes	3.0	74.5	22.7	51.7
9	99/3 983	B2	Yes	4.2	21.7	14.6	7.1
Average, patients 1-9				1.51	49.2 ± 23.1	24.4 ± 18.9	24.8 ± 13.2
10	95/15 091	AB	No	0.5	6.8	2.5	4.5
11	00/21 586	AB	No	0.3	46.9	5.6	41.4
12	95/12 211	AB	No	0.16	8.9	2.9	6.0
13	00/1 495	AB	No	0.11	12.7	2.7	10.0
14	01/4 054	AB	No	0.18	18.9	4.2	14.7
15	01/261	AB	No	0.26	24.0	3.7	20.7
16	93/23 169	B2	No	0.45	16.1	4.5	11.6
17	00/3 045	B2	No	1.8	17.6	9.8	7.8
18	97/6 635	B2	No	0.06	46.9	2.4	44.5
19	01/5 447	B2	No	0.26	27.0	5.2	22.1
20	98/5 186	B2 + B3	No	0.12	13.2	3.1	10.1
21	01/6 600	B2 + B3	No	0.25	14.1	4.3	9.9
22	97/20 308	B2 + B3	No	0.16	41.4	5.1	36.3
Average, patients 10-22				0.35	20.1 ± 15.2	4.3 ± 2.0	18.4 ± 13.7
23-35 thymus controls		TFH	Yes	1.0-3.3	17.6-55.6	8.1-32.8	9.5-22.2
Average, patients 23-35 thymus controls				2.5	33.7 ± 12.7	19.1 ± 10.6	12.9 ± 3.9